AI Summary
✦ ClarthaValuation Metrics
Trading 66.3% above historical median. Valuation is rising — currently in the strongly overvalued zone (z-score: +3.36). Confidence: 83%.
Live forward EPS implies next-12-month EPS of ₹19.35. Applying the stock's normalized valuation corridor produces a fair range of ₹736.46 to ₹922.22, with base value near ₹799.35 (-27.8% vs current price).
Live forward estimate anchored to the company's historical valuation corridor.
Forward EPS
₹19.35
Forward P/E
57.2x
Base Fair Value
₹799.35
Fair Range
₹736.46 - ₹922.22
Upside To Base
-27.8%
Estimate Source
Live forward EPS
Growth Estimate
+28.2%
5Y Average
46.36
Current
68.71
Overvalued
47.66
Undervalued
38.06
5Y Average
36.47
Current
54.05
Overvalued
41.36
Undervalued
29.69
5Y Average
12.48
Current
18.50
Overvalued
14.16
Undervalued
10.17
Peers & Comparison
Sector: Health Care · Theme: Pharmaceuticals
| Company | Rev. Growth | Margin | P/E | vs Avg | 52W Perf. |
|---|---|---|---|---|---|
CAPLIN POINT LAB LTD. CAPLIPOINTPharmaceuticals | +19.0% | 29.3% | 31.5x Undervalued | -41% vs avg | +15.8% |
COHANCE LIFESCIENCES LTD COHANCEPharmaceuticals | -23.1% | 5.0% | 169.3x Premium | +215% vs avg | -52.9% |
ALIVUS LIFE SCIENCES LTD ALIVUSPharmaceuticals | +6.4% | 23.3% | 28.0x Undervalued | -48% vs avg | +47.6% |
AKUMS DRUGS AND PHARMA L AKUMSPharmaceuticals | +13.9% | 6.5% | 39.6x Undervalued | -26% vs avg | +61.7% |
BLUE JET HEALTHCARE LTD BLUEJETPharmaceuticals | -17.4% | 26.5% | 44.0x Undervalued | -18% vs avg | -25.4% |
ABBOTT INDIA LIMITED ABBOTINDIAPharmaceuticals | +6.5% | 22.4% | 37.8x Undervalued | -30% vs avg | -15.8% |
IPCA LABORATORIES LTD IPCALABPharmaceuticals | +6.3% | 11.8% | 40.0x Undervalued | -26% vs avg | +28.0% |
AJANTA PHARMA LIMITED AJANTPHARMPharmaceuticals | +24.8% | 19.6% | 39.8x Undervalued | -26% vs avg | +30.6% |
SUDEEP PHARMA LIMITED trades at a premium (68.7x vs peer avg 53.8x), implying higher growth or quality expectations from the Pharmaceuticals cohort. Peers include CAPLIN POINT LAB LTD., COHANCE LIFESCIENCES LTD, ALIVUS LIFE SCIENCES LTD — selected based on business model, industry classification, market cap similarity, and business theme alignment.
Financials
Financial chart data is not available for this company right now.
Results
Income statement data not available.
All values in ₹ Crores unless otherwise stated. Source: Company filings.